The Clinical Research and Equipment industry is up 3.2% in the last week, with Samsung BiologicsLtd up 2.9%. In the same time, DT&CRO was down 11%. This takes the industry's 12 month performance to a gain of 18%. As for the next few years, earnings are expected to grow by 15% per annum.
Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | ₩68.9t | ₩4.5t | ₩731.7b | 18.8x | 94.2x | 15.2x |
Sun, 23 Jun 2024 | ₩59.4t | ₩4.6t | ₩691.8b | 18.2x | 85.9x | 12.9x |
Tue, 21 May 2024 | ₩62.0t | ₩4.4t | ₩663.4b | 20.1x | 93.5x | 14.1x |
Thu, 18 Apr 2024 | ₩62.0t | ₩4.7t | ₩654.7b | 18.6x | 94.7x | 13.3x |
Sat, 16 Mar 2024 | ₩65.3t | ₩4.6t | ₩636.6b | 28.9x | 102.5x | 14.1x |
Mon, 12 Feb 2024 | ₩63.4t | ₩4.5t | ₩714.4b | 33.8x | 88.8x | 14x |
Wed, 10 Jan 2024 | ₩60.0t | ₩4.5t | ₩721.5b | 33x | 83.2x | 13.2x |
Fri, 08 Dec 2023 | ₩56.5t | ₩4.5t | ₩721.6b | 31.4x | 78.3x | 12.4x |
Sun, 05 Nov 2023 | ₩55.4t | ₩4.4t | ₩660.9b | 23.4x | 83.8x | 12.6x |
Tue, 03 Oct 2023 | ₩54.3t | ₩4.4t | ₩660.9b | 30.3x | 82.1x | 12.3x |
Thu, 31 Aug 2023 | ₩59.9t | ₩4.4t | ₩679.0b | 29.3x | 88.2x | 13.6x |
Sat, 29 Jul 2023 | ₩60.9t | ₩4.2t | ₩673.4b | 28.3x | 90.4x | 14.5x |
Mon, 26 Jun 2023 | ₩58.2t | ₩4.2t | ₩666.5b | 29.9x | 87.3x | 13.7x |
Wed, 24 May 2023 | ₩62.0t | ₩4.3t | ₩623.2b | 27.4x | 99.6x | 14.4x |
Fri, 21 Apr 2023 | ₩61.4t | ₩4.1t | ₩626.3b | 28.9x | 98.1x | 15x |
Sun, 19 Mar 2023 | ₩62.9t | ₩4.0t | ₩715.4b | 26.6x | 87.9x | 15.7x |
Tue, 14 Feb 2023 | ₩63.0t | ₩3.5t | ₩427.8b | 20.7x | 147.2x | 18.1x |
Thu, 12 Jan 2023 | ₩62.6t | ₩3.4t | ₩428.7b | 20.5x | 146.1x | 18.2x |
Sat, 10 Dec 2022 | ₩64.5t | ₩3.4t | ₩428.7b | 19.6x | 150.5x | 18.8x |
Mon, 07 Nov 2022 | ₩67.1t | ₩3.0t | ₩448.5b | 22.8x | 149.6x | 22.5x |
Wed, 05 Oct 2022 | ₩63.2t | ₩3.0t | ₩448.5b | 22.3x | 141x | 21.2x |
Fri, 02 Sep 2022 | ₩65.0t | ₩3.0t | ₩452.1b | 25.4x | 143.9x | 22x |
Sun, 31 Jul 2022 | ₩68.1t | ₩2.7t | ₩454.7b | 27.5x | 149.8x | 25.1x |
Tue, 28 Jun 2022 | ₩63.8t | ₩2.7t | ₩454.7b | 28.7x | 140.2x | 23.5x |
Thu, 26 May 2022 | ₩65.9t | ₩2.7t | ₩465.3b | 21.8x | 141.7x | 24.6x |
Sat, 23 Apr 2022 | ₩59.6t | ₩2.4t | ₩379.4b | 24.5x | 157x | 24.6x |
Mon, 21 Mar 2022 | ₩61.8t | ₩2.4t | ₩393.3b | 26.4x | 157.1x | 25.4x |
Wed, 16 Feb 2022 | ₩55.2t | ₩2.3t | ₩412.7b | 24x | 133.7x | 23.5x |
Fri, 14 Jan 2022 | ₩64.8t | ₩2.3t | ₩412.7b | 27.9x | 157.1x | 27.6x |
Sun, 12 Dec 2021 | ₩67.6t | ₩2.3t | ₩412.7b | 29.4x | 163.8x | 28.8x |
Tue, 09 Nov 2021 | ₩61.3t | ₩2.1t | ₩329.9b | 25.9x | 185.8x | 28.5x |
Thu, 07 Oct 2021 | ₩59.0t | ₩2.1t | ₩329.9b | 24.3x | 178.9x | 27.5x |
Sat, 04 Sep 2021 | ₩71.5t | ₩2.2t | ₩336.8b | 36x | 212.2x | 32.3x |
Mon, 02 Aug 2021 | ₩68.9t | ₩2.2t | ₩336.8b | 35.1x | 204.7x | 31.2x |
204.7x
How does South Korean Clinical Research and Equipment compare with similar industries?
KR Market | -3.99% | |
Healthcare | 1.34% | |
Life Sciences | 2.64% | |
Clinical Research and Equipment | 2.64% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A207940 Samsung BiologicsLtd | ₩915.00k | 9.6% +₩5.7t | 16.7% | PE72.7x | |
A141080 LigaChem Biosciences | ₩80.90k | 3.3% +₩94.7b | 135.9% | PS51.2x | |
A038290 Macrogen | ₩22.35k | 19.4% +₩36.2b | 6.4% | PS1.7x | |
A445680 Curiox Biosystems | ₩44.30k | 4.2% +₩14.5b | n/a | PS57.2x | |
A246250 SLS BIO | ₩4.08k | 22.7% +₩10.3b | -12.1% | n/a |